Brian R. Berridge

Adipsin, a Biomarker of Gastrointestinal Toxicity Mediated by a Functional γ-Secretase Inhibitor

George H. Searfoss, William H. Jordan, David O. Calligaro et al. · Journal of Biological Chemistry · 2003 · 336 citations · Full text

Life Sciences, Pharmacology, Toxicology +17

Hepatic and glucagon-like peptide-1–mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors

Kyle W. Sloop, Julia X.C. Cao, Angela M. Siesky et al. · Journal of Clinical Investigation · 2004 · 215 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Current challenges in the evaluation of cardiac safety during drug development: Translational medicine meets the Critical Path Initiative

Jonathan P. Piccini, David J. Whellan, Brian R. Berridge et al. · American Heart Journal · 2009 · 125 citations

Medicine, Cardiology, Pharmacology +15

Introduction to a manuscript series on the characterization and use of microphysiological systems (MPS) in pharmaceutical safety and ADME applications

Kristin Fabre, Brian R. Berridge, William R. Proctor et al. · Lab on a Chip · 2020 · 106 citations

Pharmacy, Toxicology, Biomems +12

Perturbation of microRNAs in Rat Heart during Chronic Doxorubicin Treatment

Caterina Vacchi‐Suzzi, Yasmina Bauer, Brian R. Berridge et al. · PLoS ONE · 2012 · 94 citations · Full text

Medicine, Cardiology, Pharmacology +17